Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin microspheres in locally advanced or metastatic prostate cancer
CTR20200200Phase 3Completed
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Apr 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in prostate cancer (PCa), sponsored by Livzon Pharmaceutical Group Inc.. Started Apr 2020; status: completed.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20200200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200200.